These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 33747954)

  • 1. Clinical Value of ctDNA in Hematological Malignancies (Lymphomas, Multiple Myeloma, Myelodysplastic Syndrome, and Leukemia): A Meta-Analysis.
    Tan X; Yan H; Chen L; Zhang Y; Sun C
    Front Oncol; 2021; 11():632910. PubMed ID: 33747954
    [No Abstract]   [Full Text] [Related]  

  • 2. Diagnostic and prognostic value of circulating tumor DNA in gastric cancer: a meta-analysis.
    Gao Y; Zhang K; Xi H; Cai A; Wu X; Cui J; Li J; Qiao Z; Wei B; Chen L
    Oncotarget; 2017 Jan; 8(4):6330-6340. PubMed ID: 28009985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical value of ctDNA in upper-GI cancers: A systematic review and meta-analysis.
    Creemers A; Krausz S; Strijker M; van der Wel MJ; Soer EC; Reinten RJ; Besselink MG; Wilmink JW; van de Vijver MJ; van Noesel CJM; Verheij J; Meijer SL; Dijk F; Bijlsma MF; van Oijen MGH; van Laarhoven HWM
    Biochim Biophys Acta Rev Cancer; 2017 Dec; 1868(2):394-403. PubMed ID: 28801248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Significance of Circulating Cell-Free DNA Detection in Multiple Myeloma: A Meta-Analysis.
    Ye X; Li W; Zhang L; Yu J
    Front Oncol; 2022; 12():852573. PubMed ID: 35252019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating tumor DNA is effective for the detection of EGFR mutation in non-small cell lung cancer: a meta-analysis.
    Qiu M; Wang J; Xu Y; Ding X; Li M; Jiang F; Xu L; Yin R
    Cancer Epidemiol Biomarkers Prev; 2015 Jan; 24(1):206-12. PubMed ID: 25339418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Circulating Tumor DNA With Disease-Free Survival in Breast Cancer: A Systematic Review and Meta-analysis.
    Cullinane C; Fleming C; O'Leary DP; Hassan F; Kelly L; O'Sullivan MJ; Corrigan MA; Redmond HP
    JAMA Netw Open; 2020 Nov; 3(11):e2026921. PubMed ID: 33211112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic value of various liquid biopsy methods for pancreatic cancer: A systematic review and meta-analysis.
    Zhu Y; Zhang H; Chen N; Hao J; Jin H; Ma X
    Medicine (Baltimore); 2020 Jan; 99(3):e18581. PubMed ID: 32011436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the diagnostic and prognostic clinical values of circulating tumor DNA and cell-free DNA in pancreatic malignancies: a comprehensive meta-analysis.
    Arayici ME; İnal A; Basbinar Y; Olgun N
    Front Oncol; 2024; 14():1382369. PubMed ID: 38983931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic value of circulating tumor DNA in molecular characterization of glioma: A meta-analysis.
    Kang Y; Lin X; Kang D
    Medicine (Baltimore); 2020 Aug; 99(33):e21196. PubMed ID: 32871983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating tumor DNA as a prognostic indicator in resectable pancreatic ductal adenocarcinoma: A systematic review and meta-analysis.
    Lee JS; Rhee TM; Pietrasz D; Bachet JB; Laurent-Puig P; Kong SY; Takai E; Yachida S; Shibata T; Lee JW; Park HC; Zang DY; Jeon K; Lee J; Kim M; Kim HS; Kang HJ; Lee YK
    Sci Rep; 2019 Nov; 9(1):16971. PubMed ID: 31740696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical applications of circulating tumor DNA in hematological malignancies: From past to the future.
    Li JY; Zuo LP; Xu J; Sun CY
    Blood Rev; 2024 Nov; 68():101237. PubMed ID: 39261219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association Between Liquid Biopsy and Prognosis of Gastric Cancer Patients: A Systematic Review and Meta-Analysis.
    Gao Y; Xi H; Wei B; Cui J; Zhang K; Li H; Cai A; Shen W; Li J; Rosell R; Chao J; Chen T; Klempner S; Qiao Z; Chen L
    Front Oncol; 2019; 9():1222. PubMed ID: 31850190
    [No Abstract]   [Full Text] [Related]  

  • 13. Diagnostic and prognostic value of carcinoembryonic antigen in pancreatic cancer: a systematic review and meta-analysis.
    Meng Q; Shi S; Liang C; Liang D; Xu W; Ji S; Zhang B; Ni Q; Xu J; Yu X
    Onco Targets Ther; 2017; 10():4591-4598. PubMed ID: 28979147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluating the Diagnostic Potentials of Circulating Tumor DNA against Melanoma: A Systematic Review and Meta-Analysis.
    Zhang J; Qian D; Xu X; Xu M; Wang K; Lu H; Shen G
    J Oncol; 2022; 2022():6233904. PubMed ID: 36276290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating tumor DNA is effective for detection of KRAS mutation in colorectal cancer: a meta-analysis.
    Tang M; Deng Z; Li B; Peng Y; Song M; Liu J
    Int J Biol Markers; 2017 Oct; 32(4):e421-e427. PubMed ID: 28885658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating HPV cDNA in the blood as a reliable biomarker for cervical cancer: A meta-analysis.
    Gu Y; Wan C; Qiu J; Cui Y; Jiang T; Zhuang Z
    PLoS One; 2020; 15(2):e0224001. PubMed ID: 32027658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic and Clinicopathological Significance of MiR-155 in Hematologic Malignancies: A Systematic Review and Meta-analysis.
    Tang L; Peng YZ; Li CG; Jiang HW; Mei H; Hu Y
    J Cancer; 2019; 10(3):654-664. PubMed ID: 30719163
    [No Abstract]   [Full Text] [Related]  

  • 18. Serum 25-hydroxyvitamin D levels and prognosis in hematological malignancies: a systematic review and meta-analysis.
    Wang W; Li G; He X; Gao J; Wang R; Wang Y; Zhao W
    Cell Physiol Biochem; 2015; 35(5):1999-2005. PubMed ID: 25871640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of EGFR and KRAS in circulating tumor DNA in patients with advanced non-small cell lung cancer: a systematic review and meta-analysis.
    Fan G; Zhang K; Ding J; Li J
    Oncotarget; 2017 May; 8(20):33922-33932. PubMed ID: 28430611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of urine fibronectin as a non-invasive diagnostic biomarker in bladder cancer patients: a systematic review and meta-analysis.
    Dong F; Shen Y; Xu T; Wang X; Gao F; Zhong S; Chen S; Shen Z
    World J Surg Oncol; 2018 Mar; 16(1):61. PubMed ID: 29562940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.